Clinical cases of “MR-negative” myelopathy amid SARS-CoV-2 infection
Open Access
- 15 December 2023
- journal article
- research article
- Published by Baltic Medical Education Center in Marine Medicine
- Vol. 9 (4) , 97-106
Abstract
INTRODUCTION. Neurological complications are often observed in patients with a new coronavirus infection. Cerebrovascular diseases prevail among them. There is damage to the peripheral nervous system and spinal cord of various kind, including inflammatory and vascular myelopathy. The incidence of myelopathy syndrome among all neurological complications of the new coronavirus infection reaches 3%. OBJECTIVE. To characterize clinical and instrumental features of the rare case – “МR-negative” myelopathy amid SARS-CoV-2 infection. MATERIALS AND METHODS. The article describes a clinical case of myelopathy, associated with COVID-19 without structural changes in the spinal cord on MR-imaging using standard pulse sequences, however, visualized via spinal tractography. CONCLUSION. COVID-19 associated myelopathy is one of the characteristic complications amid the new coronavirus infection. To verify “MR-negative” damage to the central nervous system in COVID-19, advanced protocols of MRI studies might be used, including the promising method – МR-tractography.Keywords
This publication has 13 references indexed in Scilit:
- Neurological manifestations of COVID-19: A comprehensive literature review and discussion of mechanismsJournal of Neuroimmunology, 2021
- MRI negative myelopathy post mild SARS-CoV-2 infection: vasculopathy or inflammatory myelitis?Journal of NeuroVirology, 2021
- Global Incidence of Neurological Manifestations Among Patients Hospitalized With COVID-19—A Report for the GCS-NeuroCOVID Consortium and the ENERGY ConsortiumJAMA Network Open, 2021
- 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health recordsThe Lancet Psychiatry, 2021
- Acute Transverse Myelitis (ATM):Clinical Review of 43 Patients With COVID-19-Associated ATM and 3 Post-Vaccination ATM Serious Adverse Events With the ChAdOx1 nCoV-19 Vaccine (AZD1222)Frontiers in Immunology, 2021
- High frequency of cerebrospinal fluid autoantibodies in COVID-19 patients with neurological symptomsBrain, Behavior, and Immunity, 2021
- Neuroanatomical substrates of generalized brain dysfunction in COVID-19Intensive Care Medicine, 2020
- Neurological associations of COVID-19The Lancet Neurology, 2020
- SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genesNature Medicine, 2020
- The disease (syndrome) of Marchiafava-BignamiRussian Medicine, 2016